- The company tested its vaccine on 10 adults and 10 elderly adults
- The vaccine did not report any serious adverse events
Moderna announced on Wednesday that in an early-stage clinical trial, its potential corona virus vaccine has been able to generate a good immune response.
Each participant received two doses. Each dose was 100 micrograms of the v....
Tags : Moderna, Corona Virus vaccine, COVID - 19, Corona virus pandemic, Corona virus patients ,